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Abstract
During  the  recent  decades,  soaring  progresses  in  vascular  disease  knowledge,
particularly in critical limb ischemia (CLI) treatment, enhanced novel diagnostic and
interventional  strategies  with  high  serviceableness  in  patient’s  selection,  arterial
recanalization, and dedicated ischemic ulcer follow-up. However, despite undeniable
advances in medical technology and clinical judgment, limb salvage, the ambulation
recovery, and patient’s survival seem only scarcely affected in this heterogeneous CLI
group, particularly concerning the diabetic and renal patients. Innovative strategies
such as “end artery occlusive disease” treatment or “wound-targeted revascularization” were
equally  proposed by following the  angiosomal  anatomical  distribution associating
individual foot collateral assessment in a unified macro- and micro-circulatory judgment.
However, despite encouraging clinical results, prospective evidence still lacks on this
concern. It also appears that specific wounds could not always stand for the lowest
perfusion areas according to current CLI criteria, since severe neuropathy, inflammatory
swelling, local infection, and skin trauma may add complementary hindrances to tissue
viability.
The present chapter endeavor to summarize main available treatment principles for
ischemic ulcer recovery that every modern practitioner eventually disposes in an
updated contemporary view.”
Keywords: wound healing, critical limb ischemia, diabetic foot, angiosome, limb re-
vascularization
Motto: ‘Each ulcer is unique in complexity and deserves flexible understanding and
control of whole individual tissue recovery challenges’ (Current clinical observation)
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1. Introduction
During centuries, wound healing was believed to be part of a mysterious process that addresses
only inspirational approaches of secret practitioner’s experience. Outstanding scientific
advances over the last 50 years revealed real complexity of this staged process, astonishing as
life’s unfolding itself. This natural course seems to bear thousands of overlapping and
indissoluble processes [1]. Today’s knowledge, beyond new high-performance techniques for
revascularization and tissue engineering [1], affords additional key data about intimate
mechanisms of ischemic threat, ulcer formation, and steps to wound recovery [1, 2]. In the
recent decades, this proper knowledge enhanced complementary diagnostic and interven-
tional strategies with high serviceableness in patient’s selection, arterial recanalization, and
dedicated ulcer follow-up [1, 3]. However, despite soaring progress in medical technology and
clinical judgment for critical limb ischemia (CLI) wound treatment, limb salvage, and patient’s
survival seem only scarcely affected [1–3]. This assertion dwells particularly true in diabetic
and renal patients who exhibit ischemic foot wounds [1, 2]. Outstanding advances in basic
research and clinical management toward better tissue regeneration, unfortunately, seem to
confront with parallel increasing of CLI subjects each year [1]. It becomes obvious nowadays
that ischemic ulcer healing implies a convergent treatment for multifaceted presentations in
patients with multiple arterial and systemic affectations [1–3].
The present chapter endeavor to summarize main treatment principles for CLI ulcer recovery
that every modern practitioner eventually disposes in an updated contemporary view.
2. Historical perspectives and advancements in ischemic wounds treatment
Wound healing approaches are probably old as the history of medicine. During centuries,
several significant breakthroughs, however, marked significant progress in wound repair,
following thorough scientific understanding. Starting with the Ancient World, according to
the oldest medical record found on a Sumerian clay tablet (2100 BC) [4], cleansing and
bandaging the wound was noted to represent the central “healing gestures” to be practiced in
the healing course [4]. The Ancient Egyptians (1600 BC–1550 BC) also mention the use of
mixtures (honey, grease, and lint) for wound regeneration, however, without apparent
etiologic segregation [5, 6]. They also displayed an impressive science of bandaging, including
herbal extracts and resins (probably the first coordinated bandages ever mentioned) [5].
Hippocrates in the ancient Greece originally devised approach methods for acute and chronic
wounds [6]. Later on, Cornelius A. Celsius marked a momentous step in wound care history
by his original description of the “four cardinal signs of inflammation,” including first
“gangrenous foot” delineation in his eight-volume Compendium of Medicine (41 BC) [6]. A
substantial contribution to ulcer’s classification and healing understanding is appointed by
outstanding surgical work of Ambroise Parré in the Renaissance era about the treatment of
gunshot wounds including “the gangrenous battlefield limb” [7]. During the next centuries,
many new ideas in wound management were unfortunately rejected by lack of validation and
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time-related historical tendencies. Wound healing understanding was subsequently devel-
oped by Joseph Lister’s [8] and by Louis Pasteur’s remarkable clinical research [8, 9] adding
relevant knowledge for bacterial colonization and sepsis development, particularly in the
ischemic ground [9]. More recently, notable breakthroughs in comprehending the complexity
of wound healing cascade were added by Virchow [10], owning establishment of histopathol-
ogy as an autonomous discipline [6, 10], and by first isolation of “epidermal growth factor” as
a mitotic stimulant in 1962 [11].
Probably one of the most ponderous discoveries in the same period was the defining structure
of DNA and RNA by Franklin, Watson, and Crick [6]. Parallel advances were noted in surgical
and interventional revascularization techniques for tissue healing perceived in a hemodynamic
ischemic perspective. Leading milestones in arterial flow imaging were marked by first
arteriographic diagnostic reported by Brooks in 1924 [12], followed by first translumbar
aortography described by Dos Santos in 1929 [13], both with considerable influence in more
accurate inferior limb arterial disease diagnostic. First Doppler ultrasound assessment of
atherosclerotic occlusive disease by noninvasive method was reported by Strandness [14] in
1966. All these diagnostic methods have borne huge influence first in distinguishing arterial
from nonischemic wounds, and further for separating arterial from venous limb ulceration.
The current ischemic injury diagnostic era yet institutes since the computed tomography (CT)
scanning and magnetic resonance imaging (MRI) have become an integrated part of ongoing
peripheral arterial flow evaluation [15]. For that arterial surgery enables high limb salvage
nowadays, the achievement of several important steps was mandatory. The first lumbar
sympathectomy in 1924 by Labat [16], the heparin use since 1937 [17], the Kunlin’s first
saphenous vein graft in 1951 [18] and the first Dacron [19], and polytetrafluoroethylene
(PTFE) [20] prothesis utilization, all had tremendous influences in modern surgical revascu-
larization for wound healing [1–3, 20].
Traditionally during years, open surgical bypass represented the main effective treatment
strategy for tissue recovery and limb salvage [1, 21]. In addition to outstanding surgical
revascularization advances, new transcatheter endovascular techniques emerged and rapidly
evolved in CLI treatment arena during the last three decades [21]. They seem to improve the
perioperative morbidity-mortality and the length of hospital stay, affording comparable limb
preservation rates [1–3, 21]. Owning remarkable low invasiveness and reproducibility, the
percutaneous transluminal angioplasty (PTA) and stenting (first promoted by Gruntzig in 1974
and by Dotter [20] in 1964) rapidly gained a wide utilization in the coronary, but also in the
peripheral arterial disease (PAD) current treatment [21]. Although the “stent” term derives
from Charles Stent (1807–1885), an English dentist who used this term for creating customed
dental molds [21], the idea to modulate vascular lumen by diligent metallic implants had great
issues in vascular practice. During the next decades, new “bare” or “covered stents” were
imagined, together with new “stent grafts” originally pioneered by Volodos and Parodi in the
treatment of aortic aneurysmal disease around 1985–1990s [22]. Novel “drug eluted” devices
including balloons and stents have been successfully launched during the last decade with
promising clinical results [1, 21].
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Following parallel scientific emancipation, new strategies as to improve ischemic tissue
healing were cast in parallel medical disciplines. Thus, in 1987, Taylor and Palmer initially
described the “angiosome” model of human body vascularization [23] and auspiciously
implemented the concept among particular plastic reconstructive surgery applications. This
significant breakthrough in tissue perfusion understanding was succeeded by its first use in
CLI limb salvage by Attinger and colleagues 20 years later [24], using “topographical” or
angiosome-guided bypasses to the foot ischemic wounds [24]. Not surprisingly, starting with
2008–2010s, and up to the contemporary period, new endovascular “wound-directed”
revascularization applications were described with promising wound healing and limb
preservation results [25, 26]. All these progresses have added and undoubtedly will add
complementary understanding in ischemic ulcer treatment, owning more precise revascula-
rization selection since specific “wound-targeted” revascularization is performed [24–26].
3. Demographics, etiologic factors, and social implications of PAD with its
most severe presentation represented by critical limb ischemia
Recent demographic data suggest that more than 200 million individuals worldwide suffer
from varied forms of the PAD that represent a 24% increase over the last decade and concern
all socioeconomic strata [27, 28]. The economic weight of PAD was proven to be ponderous
[28]. It has meant that the total costs of vascular-related hospitalizations climbed to 21 billion
dollars in the USA in 2004, and this threshold seems to rise each year continually [28]. Critical
limb ischemia as a consequence of severe infra-inguinal atherosclerosis embodies extreme
forms of PAD and currently associates rest pain and ischemic ulcers (corresponding to Fontaine
stages III/IV and Rutherford categories 4-5 ischemic limb presentations) [1–3].
The term of CLI is commonly used for patients who exhibit symptoms of severe arterial
hypoperfusion for more than 2 weeks [3, 27]. Elementary CLI diagnosis is made by clinical
exam, anatomical stratification, and hemodynamic evaluation of flow disturbances over
accessible arterial paths [1, 3, 27]. Defining and analyzing large CLI groups of patients,
however, prove to be difficult [2–4].
These hindrances are mainly determined by (1) the vast heterogeneity of underlying arterial
diseases [1, 27], (b) the various appended risk factors [1–3, 27], (c) the multilevel spread of
arterial lesions [1, 27] (d) by concurrent systemic pathologies [27], (e) the scarce follow-up data
[3, 27], and (f) the lack of synchronous macro- and microvascular apprehension for gradual
hypoxic limb changes [1, 27–31]. It is known that without precocious recognition and aggres-
sive treatment, CLI invariably inflicts significant morbidity and high rates of major amputation
and mortality [1–3, 27–30].
To date, the likelihood of death within the first 6 months of CLI diagnosis has been estimated
to reach 20% (all etiologies confounded) and exceeds 50% at 5 years following prime docu-
mented onset [27–32]. Contemporary studies reveal that patients with PAD (and particularly
those with CLI) are more likely to experience simultaneous coronary or cerebral vascular
disease, bearing a higher risk of early death [1–3, 27]. The risk for developing PAD seems
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considerably increased in diabetic and renal patients, prone to more frequently experience
systemic ischemic events compared to general population [1–3, 27–31].
Several risk factors that lead to lower limb major amputation in patients having ischemic
wounds were described, including increasing age, being male, being African American, having
peripheral neuropathy, and developing infected ulcers [1, 2, 27–29]. The Trans-Atlantic Inter-
Society initial Consensus (TASC) II document showed that more than 15% of diabetic subjects
will unfold a foot ulcer during their lifetime while 14–24% of them, unfortunately, will require
amputation [3]. It is also valued that more than 170 million people suffer nowadays from
diabetes mellitus, and their worldwide number is anticipated to attain 366 million by 2030 [1].
In this particular cohort of diabetic patients during the first year of CLI diagnosis, 40–50%
among them may experience foot amputation while 20–25% among them will die [1, 2, 27].
Nevertheless, by applying optimal revascularization and local wound treatment as early as
possible, up to 85% of amputations can be prevented [3].
The social burden of the metabolic syndrome and particularly the diabetic systemic athero-
sclerotic disease is tremendous for the patient, the medical care organization, and public
communities [1, 2, 28, 31].
Particularly concerning arterial inferior limb ulcers (all arterial pathologies confounded),
current reports document 18–29% prevalence among 60 years or older patients who interest-
ingly bear equal rates as much younger (50-year-old) individuals associating diabetes or
tobacco use [33].
4. Critical limb ischemia ulcers: do we meet the current clinical needs?
Postischemic tissue recovery implies simultaneous alignment of several distinct physiological
processes [33]. Inasmuch their entire clinical signification remains only partially controlled [27,
30, 33], their unaltered unfolding dwells prerequisite. Among numerous molecular and
cellular events that clearly overpass the purposes of this chapter, some practical aspects may
be however useful to be highlighted and are briefly summarized in the sections below.
4.1. Leading physiological mechanisms in wound recovery and appended phases of
revascularization
It is accepted that mechanisms concerning tissue regeneration are strongly influenced by the
type and thickness of tissue layer affectation, also by their capacity for healing [1, 33]. The
retrieval of CLI threat resets in motion the regular “cascade” of reconstructive tissue events
leading in normal circumstances (absence of systemic risk factors for healing) to long-lasting
tissue repair [33, 34]. Full-thickness wound regeneration following most CLI revasculariza-
tions concerns the skin, the underlying subcutaneous and the deep muscular compartments.
Currently, this process is depicted in three schematic phases: the inflammatory stage (the “lag”
phase), the “tissue formation” (or the “proliferative”) phase, and the “tissue remodeling”
phase [34]. It is important to note that this “allotment” is somewhat conventional since all three
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stages are commonly overlapping to some degree [33, 34]. Activating cells that participate in
one phase usually produce biological triggers indispensable to interlock tissue molding into
the next phase [34]. These stages are routinely conditioned by initial hemostasis and by
intentional arterial revascularization, both representing fundamental activating processes [33–
35]. Most details concerning these enthralling multimodal events are largely depicted in
available histopathology literature and will not be further characterized in this section.
During the same sequential process, the ischemic burden relief sets in motion three parallel
hemodynamic regenerative phases [35]. These stages are conceptualized as (1) the initiatory flow
redistribution phase (concerning “large” remnant collaterals surrounding the ischemic wound
zone), (2) the early or “mid-term” flow dispensation (regarding the “rescue” or “small”
collaterals and arterioles), and (3) the retarded postischemic phase, essentially characterized by
the arteriogenesis, the angiogenesis processes [33–35]. Alike most biological chain-processes,
these three flow-redistribution phases exhibit specific time overlapping in their activation,
according to concomitant vascular risk factors and individual patterns of arterial occlusive
disease [35]. This particular knowledge may enable the clinician to choose better appropriate
diagnostic and treatment methods in a timely approach for every ischemic wound follow-up
[33, 35].
4.2. Main pathophysiological aspects in ischemic wound healing and related clinical
presentations
To date, the exact mechanisms and time periods conducting to chronic ischemic ulceration are
not completely understood [30, 31, 33, 34, 36]. Most arterial ulcers are encountered over the
age of 65 as people live longer nowadays [3, 33]. Arterial ulcers are ranked to constitute about
12–19% among all leg ulcers [33, 37] while mixed venous-arterial or combined neuro-ischemic
tissue defects may concern 15% [37] up to 24% [29–31] of these patients, respectively. There
were described either as “spontaneous” ulcerations (typically involving the forefoot and toes
as progressive collateral occlusion occurs) or as “post-minor trauma” wounds since inadequate
arterial flow proves ineffective to increased oxygen demands for cicatrization [34, 38]. Bed-
ridden patients with PAD represent another high-risk category to develop pressure heel
ischemic ulcers on preexisting vascular impairment [37, 38]. For this particular cohort exhib-
iting ischemic hind foot ulcers, current guidelines emphasize that prevention by scrupulous
heel elevation or soft tissue contact interposition is mandatory [3, 28, 38].
The TASC II fundamental CLI criteria [3] as absolute ankle pressure (AP) inferior to 50–70 mm
Hg, or diminished toe pressure (TP) below 30–50 mm Hg are unanimously accepted [3]. A
series of parallel predisposing factors for ischemic tissue damage were evinced in the last
decade. They either concern the arterial perfusion (tobacco use, dyslipidemia, hypertension,
weight excess, hyperglycemia, hyperhomocysteinemia, etc.), or specific foot conditions
(peripheral neuropathy, inflammation, edema, infection, bedridden status, hypoalbuminemia,
hyperglycemia, uremia, cortisone therapy, etc.), all with huge influence on peripheral tissue
regeneration [1–3, 27, 33–35, 37, 38]. Although arterial ulcers theoretically may appear
anywhere on the ischemic limb [3, 33], the presence of multilevel CLI arterial disease inflicts
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more distal localizations, particularly in subjects with deprived foot collateral reserve [1, 25,
29, 30].
Beyond common atherosclerotic arterial ulcers, other arterial-related ulcers were described
such as superficial hypertensive wounds, peripheral embolic tissue defects (owning 0.01–0.2
mm. cholesterol particles), those associated with connective tissue arteritis, those affecting
hypercoagulable states, or following microangiopathic lesions, within parallel to mixed
nutritional, hemolytic, or neurologic disorders [33, 34, 36].
4.3. What determines ischemic tissue defects to slide toward chronicity and necrosis? Is there
a conjuring threshold to consider?
It has been showed that in healthy individuals, peripheral wounds promptly tend to recover
owning adapted cell’s metabolism, appropriate oxygen supply, essential growth factors,
cytokines, and matrix proteins inflow (Section 5.1.2.) that all endeavor to orient local tissue
damage on “steady” sequential healing process [27, 33, 36].
Since initial ischemic changes last beyond local individual compensatory reserves [30, 35], the
readapting mechanisms are gradually exhausted and local tissue homeostasis finally drifts
toward biological extinction [36, 39, 40]. Inasmuch CLI wound onset may be commonly
displayed over days or weeks [3], local infection and collateral depletion by septic thrombosis
can urge irrecoverable tissue loss appearance and make it devastating [30, 32, 35]. Probably
the real “tipping point” between viable or perished, for every inch of ischemic tissue around
the wound relies on local collateral adaptation vigor [39]. Alike other ischemic models
described in human tissues (stroke, myocardial infarction), the extent of necrosis core depends
on rescue capacity inside the “penumbra” or intermediary neighboring zone [35]. For this
transitional layer of undecided viability, a few factors strongly influence its fate. The timing
and intensity of main ischemic threat, the type of arterial pathology, the remnant upstream
arterial trunks and collaterals, and the elapsed interval to prompt debridement and revascu-
larization, play a pivotal role in any arterial ulcer progress [30, 33, 36, 40].
Daily vascular practice proves that interventionists are more likely confronted with patients
exhibiting more than one long acting adverse factors for tissue healing [39, 40]. These conditions
can be summarized as malnutrition and hypoalbuminemia, lack of compensatory arterial
collateral network, diminished arterio- and angiogenesis, peripheral edemas enhancing local
compartmental syndromes, low cardiac output, and prolonged bony prominences pressure
that collectively contribute as notable interferences in physiological cicatrization [34, 35, 37, 40].
4.4. Current CLI diagnostic: can we effectively assess the real ischemic burden?
A series of high-performance technologies conceived to assess tissue-related arterial disease
were introduced in the last two decades. These methods afford high or low invasiveness and
focus on different targets in evaluating CLI hemodynamic and tissue changes [29, 30]. With
each passing year, novel or modernized diagnostic techniques strive for accurately scoring the
degree of perfusion tissue impairment in mixed series of patients and arterial pathologies [1,
2, 27–32].
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It has been showed that first detailed clinical assessment of each tissue defect is mandatory in all
presentations [36, 38, 39, 40]. Basic characteristics of each ulcer (surface and depth), its precise
location(s), and the appended inflammatory extensions before and after revascularization
should be carefully analyzed and scored by trained clinical teams [38, 39].
The majority of available diagnostic techniques can be roughly divided into macro- and
microcirculatory investigation tools. Some “routine” noninvasive macro-vascular exams such as
the ankle-brachial index (ABI < 0.5, severe ischemia), the toe-brachial index (TBI < 0.7, presence
of PAD), the ankle and toe pressure (<40 mm Hg, threat of the limb), the exercise stress testing,
and the Doppler and Duplex assessments are well-documented and own undeniable benefits,
and drawbacks [33–35, 37, 39]. Meticulous Doppler evaluation avails real usefulness for
knowledgeable clinicians in determining antegrade versus retrograde tibial, pedal, or collat-
eral flow toward the wound zone [24, 39]. It may also yield helpful information over the
remnant “large caliber” collaterals in the targeted foot ischemic area [24, 35, 39]. A precise
mapping of lower limb arteries specifying eventual stenosis, occlusions, and secondary
collateral flow represents a valuable preoperative or follow-up guide for any interventionist in
planning wound-directed revascularization [39].
Other low-invasiveness techniques for detecting “large” arteries and collaterals include last-
generation multislice computed tomographic angiography (CTA with “Dual energy”) and the
magnetic resonance angiography (MRA adding “BOLD sequences”) [33, 39]. The “Dual
energy” CTA imaging represents a current evaluation method in our team experience for
patients with normal renal function. This technology allows accurate calcific plaques removal
in tibial and foot vessels and provides a true BTK “lumenograms” in these patients [39].
Despite notable progress in both techniques, these two methods host similar iodine or
gadolinium-based contrast disadvantages, being contraindicated in allergic patients or for
those suffering from chronic renal insufficiency [33, 39].
Unfortunately, in the daily clinical practice, most of diabetic or renal CLI patients with
threatening foot ulcers often associate advanced nephropathy that challenges the use of Iodine
or Gadolinium contrast agents.
Probably the most accustomed macro-circulatory yet invasive available test is represented by the
digital subtraction arteriography (DSA) of the inferior limb arteries [1, 3, 28, 38].
DSA is currently recognized as a “key exam” in accurate ischemic flow assessment and
classification [1–3, 38, 39]. It is cited to afford best available spatial resolution required to
establish main arterial trunks and collaterals (>500 µm diameter) morphological details toward
the wound zone [1, 3, 27, 35, 38]. DSA also enables appropriate diagnostic for eventual
anatomical variables and their collateral network in each specific arterial pattern [1, 27, 35].
This quantitative information becomes essential in understanding individual vascular anatomy
for performing eventual direct (wound targeted) or indirect (collateral supported) arterial
revascularization to the wound zone [24–26, 39]. Peripheral angiography consequently helps
in determining the most appropriate and “feasible” target vessel to be treated [23–26, 35].
It is shown that DSA affords the interventionist valuable qualitative information about the
severity of distal leg ischemia (the “desert” foot presentation). It also provides accurate
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characteristics of run-off vessels, the integrity of foot arches, and clues about potential technical
difficulties in long chronic total occlusions (CTO) recanalization (the presence of concave/
convex atherosclerotic caps) [1, 21, 29, 39]. This technology provides corresponding informa-
tion about extensive calcifications, tortuosities, and available arterial-arterial communicants
or “blush” irrigation around the ulcer’s zone [25, 26, 31, 35, 39]. Inasmuch DSA bears evoked
drawbacks due to iodine contrast (allergic or renal failure reactions), it also carries the eventual
access-related risk for hemorrhagic complications (0.8–3% of cases) [27, 33, 39].
Modern wound practitioners equally avail latest micro-vascular noninvasive diagnostic tech-
nology, with soaring applications in the last two decades. Among these methods, some showed
promising results such as the consecrated transcutaneous oxygen pressure [1–3, 33, 39]; the
novel vascular optical tomographic imaging (VOTI) [41]; the “real-time” Laser-Doppler skin
perfusion pressure [33, 35, 39]; the continuous tissue oxygen saturation foot-mapping (StO2);
and the recent 99mTc Scintigraphic, the PET, and the single-photon emission computed tomog-
raphy (SPECT) scans (owning specific CLI 3-D detection at molecular level) [35, 39]. Parallel
microcirculatory yet, more invasive exploration was recently documented gathering intraoper-
ative “Indocyanine green” angiography (ICGA) [42, 43], the “Indigo Carmine” angiography
[44], and the foot “micro-oxygen sensors” (MOXYs) technology, all with encouraging appli-
cations during wound-targeted revascularization [45].
4.5. The CLI multimodal approach: a novel contemporary concern
Bell et al. first proposed the notion of critical limb ischemia in 1982 for defining severe arterial
flow deprivation that currently inflicts major limb amputation threat [46]. In their original
publication, the authors characterize CLI essentially on macro-vascular hemodynamic criteria,
such as the measured AP <40 mm Hg in the presence of rest pain and <60 mm Hg when tissue
necrosis is noted [46]. It should be mentioned that in the original form of this concept, the
diabetic group of CLI patients was deliberately excluded since neuropathy and infection are
often associated and make more complex real ischemic stratification [46]. During the next 30
years, the term of CLI was broadly, yet most of the times inappropriately, used [29–32, 47] as
to characterize a much larger hierarchy of severe arterial presentations, including diabetic and
renal subjects [27, 30, 46–49]. Although the particular threshold from “reversible” to “irrecov-
erable” limb ischemia still dwells imprecise [27, 29, 31, 34], it is accepted that CLI often implies
a poor limb outcome without prompt revascularization [1–3, 27, 30, 46, 47]. An eloquent 1527
CLI subjects review analysis recently performed by Abu Dabrh et al. on the natural history of
untreated “severe” or “critical” ischemic limbs revealed 22% all-cause mortality, 22% major
amputation, and 35% worsening in wound evolution rates at 1 year [48]. The almost similar
observation was reported in 2016 by Vallabhaneni et al. in a 443 CLI cohort assembling more
than 60% diabetics and 20% dialyzed patients [49]. They found 32 and 56% mortality rate at 1
and 3 years, respectively, and 24 and 31% major amputation rates at the same time intervals
[49]. The authors conclude that not all patients were encompassing current ABI- and TBI-
accepted CLI macro-vascular criteria, obviously are at high risk for major amputation [49].
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We know nowadays that CLI associates a modest quality of life to the high rate of major
amputations and that about 60% of mortality is documented between 3 and 5 years following
the initial diagnostic [1–3, 32, 46, 47–49].
Parallel papers focusing on equivalent macro-vascular hemodynamic standards (ABI, TBI, AP,
TP, etc.), equally fail to explain this huge heterogeneity encountered in CLI “limb salvage” and
dedicated treatments [47–49]. Struggling to provide more accurate CLI categorization, several
conspicuous classifications systems were proposed in the last two decades [1, 3, 30, 47].
Owning the Bollinger angiographic scale [50], the Trans-Atlantic Inter-Society initial Consen-
sus (TASC I and II) [3, 51], the Rutherford staging of PAD [52], and the European recommen-
dations for CLI management [53], complementary definitions yet adding only TcPO2
microcirculatory references were settled [27, 47, 53].
In the recent years, novel PAD classification systems were developed alike the Graziani
morphologic arteriographic indexation in diabetics [54], the Toursarkissian angiographic
scoring for distal limb salvage bypass [55], and the “Jenali” tibial run-off classification system,
with appended below-the-knee intervention protocol [56]. This latest is based on three grades
for main infragenicular arterial trunks fluency associating three levels of time-related collat-
erally filling (at 3–6–9 s) [56].
Undoubtedly, all abovementioned iconographic scoring systems excel in meticulous angio-
graphic anatomy analysis, yet only partially address concomitant wound index or baseline
microcirculatory perfusion status [30, 39].
Despite real efforts in stratifying CLI intimate mechanisms, to date, all evoked classifications
add a little emphasis on coupled macro- and microcirculatory evaluation, including individual
wound characteristics [30, 39].
They also fail to quantify eventual threshold [47] below which inferior limb perfusion becomes
nonviable without opportune revascularization [27–30, 47]. The risk of developing CLI and
ischemic wounds seems considerably increased in diabetic patients, although prone to more
frequently endure systemic ischemic events compared to general population [3, 27, 31].
Contemporary clinical expertise allows better knowledge over the multifaceted “Diabetic Foot
Syndrome” (DFS) presentation that gathers arteriopathy, neuropathy, sepsis, pressure injuries,
and cellular and molecular metabolic disturbances, in myriads of different clinical archetypes
[31, 57]. A vehement need for more specific CLI delineation in these patients was increasingly
recollected in modern vascular literature.
4.6. Does healing process in diabetics follow same predictable “standards” alike other CLI
patients?
Soaring progress in arterial ulcers treatment is however confronted with an exponentially
increasing number of diabetic CLI subjects each year [1, 31]. To date, the prevalence of purely
neuropathic, ischemic, and combined neuro-ischemic foot ulcers in patients with diabetes was
estimated at 35, 15, and 50% rates, respectively [57–59].
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Reported DFS singularities include (1) the regular tibial trunks calcifications [2, 30, 31, 57] that
match the extent of local neuropathy [25, 31], (2) the “end-artery occlusive disease” (EAOD)
concept [59], (3) an impaired arterio- and angiogenesis [60], (4) a specific collateral deprivation
following chronic inflammation and septic thrombosis of small vessels [31, 35, 57–59], (5)
intrinsic vascular or matrix impaired regeneration [61], and (6) characteristic neuro-ischemic
compartmental hyper pressure foot syndromes [62].
The EAOD theory emphasizes that in the collateral-depleted diabetic limb, “each millimeter
of skin” up to the “entire foot” may rely upon one particular artery with terminal distribution
[59], while this valuable vessel may be auspiciously targeted by “wound directed” revascula-
rization, according to the angiosome concept [24–26].
Modern diabetic ulcer understanding builds a complete design of multifaceted and potentially
devastating CLI effects in these patients [2, 31, 57–62].
Enthralling scientific works in the last decade evoke a possible central mechanism playing a
pivotal role in different DFS pathological changes [59, 63]. Thus, chronic hyperglycemia may
enhance at the mitochondrial-level expanded free radicals production, altering normal
metabolic and cellular activity [63]. This malfunction affects more particularly normal
regeneration at the microcirculatory level (vasa-vasorum and vasa-nervorum) also the tissue
binding matrix [58, 59–61].
Arteriopathy and neuropathy, albeit regular DFS features (in different proportions) [58, 59],
may probably share the same pathological emergence in the vast diabetic complications
puzzle [57–59, 63].
Trying to stratify main DFS characteristics, a few classification systems were proposed. It
should be mentioned the “Wagner” stratification [64], the PEDIS (perfusion, extent/size, depth/
tissue loss, infection, sensation/neuropathy) [65], the University of Texas (UT) [66], the sepsis,
arteriopathy, denervation (SAD) scale [67], the diabetic ulcer severity score (DUSS) [68], the
multiple ulceration, wound area, pedal pulse, and ulcer duration (MAID) classification [69],
and the “St. Elian wound score system” [70], rejoicing unanimously recognized popularity and
documented clinical benefits [57–59].
However, most of these classifications fail to provide concomitant perfusion information [35,
47]; individual ulcer features [47]; infection, denervation, or gangrene specifications [47]; systemic
factors report [2, 30] (Section 4.5); and healing prognosis [2, 40, 47]. All these clinical entities
seem to bear a huge interest in healing evaluation [2, 31, 37, 39].
In same effort to fully perceive each DFS presentation, the remarkable WIfI classification [47]
recently brought together Wound grades, Ischemia levels, and foot Infection ranked in a
unitary view, as important variables for appended wound prognosis [47]. However, diabetic
neuropathy [36, 58, 71] and concurrent systemic variables influencing tissue recovery [57, 61,
72] are not included in this model of examination. In a parallel analysis, owing a consecutive
249 CLI wounds series, Azuma et al. [72] found that beyond diabetes (including neuropathy
and infection), equally end-stage renal disease (ESRD), Rutherford category 6 (including or
not the heel), and low albumin levels, represented significant factors in the complex tissue
recovery cascade beyond prompt revascularization [72].
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5. Contemporary landmarks in ischemic wounds revascularization
Expanding clinical evidence in the last three decades supports both bypass and the endovas-
cular techniques as useful strategies in CLI revascularization [1–3, 29–31]. Providing low
invasiveness, high reproducibility, and comparable limb salvage rate to open surgery [21–73],
transcatheter strategies continue to evolve with new low-profile and high-performance devices
in arterial reconstruction [21, 29, 74]. For most “high-risk” CLI patients [1, 2, 31, 34], new
endovascular approaches and techniques were designed. In succinct overview, the “drilling,”
the “subintimal,” or the “parallel wire” techniques via the ante- or retrograde accesses, the
pedal-plantar “loop,” and the femoral-femoral or transtibial collaterals angioplasties were
recently described [29, 74, 75].
Not with standing with these spectacular transcatheter performances, the “classical” bypass
for distal leg reperfusion is still imposed as a fundamental technique for CLI diabetic foot
revascularization, tissue healing, and limb preservation [1, 3, 72, 76]. High-skill distal vein
bypasses to the tibial [72], to the pedal [77], and up to the plantar or tarsal foot arteries [78]
equally by targeting remote branches of pedal arteries in some particular cases [1, 76] were
successfully documented. We now know that both surgical and endovascular techniques are
more likely complementary than competitive techniques since each of them holds major
advantages and inherent drawbacks [1, 29, 30, 79]. Endovascular techniques essentially
provide minimal invasiveness, great accessibility, and reproducibility for one or multiple
below-the-knee CTO recanalizations [1, 29, 73–75]. Alternatively, bypass offers a higher
pressure on targeted arteries and more physiological and pulsatile flow inside collaterals
around the wound zone [35, 53, 77–79]. This particularity heightens arterial-arterial collateral
shear stress and enhances rising arteriogenesis [58–60] toward further tissue cicatrization [1,
29, 35, 60, 72].
Although still heterogeneously structured [1, 73, 79], increasing contemporary clinical
observation documents equivalent limb salvage, clinical success, and survival outcomes for
bypass versus endoluminal interventions in selected groups of CLI patients [1–3, 27, 29–31, 79,
80]. Notwithstanding with initial historical considerations [79], these two strategies appear
nowadays more intricate than ever inside the conceptualized “team approach” as CLI
treatment [29, 35].
Parallel advances concerning the DFS revascularization and ischemic wound healing were
equally testified in the last two decades [1, 2, 75]. Beyond striking surgical arterial reconstruc-
tions [76–79], new tapered nitinol [81], drug-eluting stents (DES) [82], and original drug-
eluting balloon, (DEB) [83] were imagined. Novel or redesigned directional or rotational
atherectomy devices [84], together with latest “bioresorbable scaffolds” technologies [85],
represent few additional of numerous achievements that challenge today ancient technical
barriers [1, 29, 75, 81–86].
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6. New strategies for “wound targeted revascularization”
The complex cascade of tissue regeneration needs precise circumstances to unfold [85]. Beyond
high-performance techniques in reconstructing arterial flow [72–86], new strategies about
“when” and “where” to perform appropriate revascularization emerge today [1, 27, 30, 35].
Contemporary practitioners equally avail key data on the molecular mechanisms generating
ischemic threat and tissue regeneration [59–61]. This knowledge, part of a larger “integrated
multidisciplinary medicine” [87, 88], supports new strategies in limb salvage [1, 29, 48] based
on precise arterial flow mapping [23–26] and deliberate tissue healing reengineering [29–31].
A new conceptualization of ischemic wound treatment rises at present [1, 2, 33], with promising
serviceableness in patient’s stratification [47, 53, 57, 59], revascularization selection [35, 38],
and dedicated postoperative follow-up [31].
According to this modern emphasis, novel “hybrid” surgical and endovascular techniques
[89], synchronous ante- and retrograde arterial accesses [74, 90], and novel topographic
“wound-directed” revascularization (WDR) [24, 35, 91–93] proved useful to save more limbs
for major amputation. Alternatively, extreme venous limb arterialization [94, 95] and cell stem
treatment [1, 29] parallel to rising “multidisciplinary team” practice [57, 87, 88] have also been
developed and seem to revolutionize previous CLI paradigms of care [1, 29, 92–94].
6.1. The “angiosome concept” in ischemic wound healing: a succinct overview
Among all innovative strategies in CLI wound treatment, a remarkable leap was undoubtedly
marked by topographic, or intentional, wound directed arterial reconstruction [23–26, 35, 72, 91–
93]. This theory represents a unique clinical application of the angiosome concept initially
pioneered in 1987 by Taylor et al. in the plastic reconstructive surgery field [23].
Figure 1. A schematic anatomic representation of the six angiosomes of the lower leg in a forefoot/hindfoot topograph-
ic view. (1) The medial calcaneal angiosome (from the posterior tibial artery). (2) The medial plantar angiosome (posterior
tibial artery). (3) The lateral plantar angiosome (posterior tibial artery). (4) The dorsalis pedis angiosome (from the anteri-
or tibial artery). (5) The lateral calcaneal angiosome (from the peroneal artery). (6) The antero-lateral malleolar angiosome
(currently from the anterior tibial, also from the perforator branch of the peroneal artery).
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The angiosome conceptualization describes more than 44 specific 3-D tissue sectors of the
human body nourished by individual arterio-venous bundles called “the angiosomes” [23].
This anatomical representation was further referred to CLI treatment two decades later by
Attinger et al. [24], owning encouraging clinical results.
The lower leg angiosome territories. The following skin and underlying tissue zones were earlier
described as to nearly encompass six main angiosomes (Figure 1) of the foot and ankle [23–26,
91–93]:
• The medial calcaneal and appended medial and lateral plantar arteries angiosomes arising all
from the posterior tibial artery. They supply the entire plantar heel and the medial and lateral
plantar surface to the toes.
• The dorsalis pedis angiosome, downstream to the anterior tibial artery that nourishes the dorsal
foot and toes areas, also ensures the upper and anterior peri-malleolar vascularization.
• The lateral calcaneal artery angiosome branching from the peroneal artery and that supplies
the lateral, plantar heel.
• At a higher level of the superior ankle, other angiosomes were described, such as the
antero-lateral malleolar owning its correspondent antero-medial malleolar angiosomes (both
from the anterior tibial artery), and the pstero-medial malleolar angiosome following corre-
spondent branch from the posterior tibial artery, respectively [23–26, 91–93].
Figure 2. A diabetic neuro-ischemic ulcer associating cutaneous sepsis on the antero-medial aspect of the foot. (a) The
initial clinical aspect (CLI, Rutherford 5). (b) The appended angiographic aspect showing complete occlusions of the
dorsalis pedis and distal posterior tibial artery. (c) Healing aspect at three months, following (d) angiosome-targeted
revascularization by deliberately opening the dorsalis pedis artery territory (arrow).
These vascular territories are closely interconnected by numerous arterial-arterial communi-
cants [23, 24], whose caliber and density are strongly influenced by the age of patients, by each
region’s anatomy and by the manifest arterial disease triggering CLI [24, 35, 72, 96–98]. Every
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individual collateral system essentially assists blood supply between neighboring angiosomes.
These compensatory branches the so-called “choke vessels” include large-, middle-, and small-
sized arterial-arterial communicants, beyond the arterioles and capillary vessels in a vast
“compensatory arterial foot network” [24, 29, 35]. All collateral interconnections between
adjacent angiosomes are submitted to specific hemodynamic influences related to local
arteriogenesis and angiogenesis processes [35, 59, 60].
The angiosome clinical model implies a conspicuous vascular anatomical order, although subject
to specific pathophysiological changes in every CLI individual pattern. Optimal wound-targeted
revascularization probably means correct angiosome-related anatomical evaluation associated
with individual collateral-related pathophysiological judgment for each CLI presentation
[30].
Figure 3. Wound-targeted revascularization for severe forefoot sepsis and tissue necrosis, extending to the plantar side
of the hallux and toes. (a) The initial clinical aspect (CLI, Rutherford 5). (b) Healing after topographic revascularization
and multidisciplinary team care at five months. (c) The starting angiographic image showing complete posterior tibial
artery occlusion (the dominant wound territory), and the dorsalis pedis thrombosis. We can remark only a few rem-
nant collaterals (the characteristic diabetic foot collateral deprivation) represented by two lasting diagonal arteries. (d)
Endovascular plantar angiosomes-targeted revascularization by posterior tibial artery intentional reopening. (e) The
end-procedural result showing the posterior tibial, the plantar arteries, and the plantar arch reperfusion in an inten-
tional wound-directed revascularization.
In young subjects with unaltered collateral network possible post-traumatic or ischemic
injuries activate unmitigated “choke-vessels” that warrant (at some point) effective compen-
satory blood pressure between adjacent angiosomes [24, 39, 96, 97]. Atherosclerotic, inflam-
matory, or local thrombotic conditions may alter this unique natural compensatory system. As
previously described [23, 24], the foot angiosomes are 3-D dynamic and continuously inter-
acting structures [30]. Although their primary anatomical distribution seems accurately
reproduced in more than 90% of subjects (owing 6–9% eventual anatomival variants) [23, 24,
26, 91], their interconnections (“choke vessels”) are yet submitted to continuous changes,
according to each type of CLI pathology [72, 95–98].
Assessing and treating ischemic wounds in the light of the angiosome theory imposes a flexible
reflection upon how utilizing the remnant arterial-arterial connections (Figures 2 and 3) at best
flow benefit for the patient [88, 97].
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6.2. What group of ischemic ulcers may need WDR?
Inasmuch genetic collateral network warrants a remarkable “rescue system” in non-athero-
sclerotic patients, it can be dramatically hindered in specific diabetic or uremic ischemic
wounds [24, 35, 72, 96–98]. The interventionist should be aware of treating peculiar diabetic
and ESRD ischemic ulcers, for that these patients may hide huge collateral decay and poor
arterial-arterial connections among adjacent foot angiosomes [72, 97]. Eventual indirect [26] or
nonspecific revascularization [25, 93] in these subjects may fail to afford correct arterial flow to
the wound by a lack of collateral resources [25, 59, 72, 96].
Alternatively, the use of WDR principle in these cases seems to provide improved healing
results [24, 39, 72, 96–98] owning scrupulous macro- and microcirculatory evaluation, planning
for intervention and follow-up [39, 96, 97].
Despite encouraging tissue healing and limb salvage results for both, bypass and endovascular
treatment [24–26, 91–93], uncertainty still dwells concerning the utility of angiosome-oriented
revascularization in specific CLI groups of patients dysplaying different etiologies of arterial
disease [35, 72, 96, 97]. Growing clinical expertise, however, seems to support WDR in “low-
collateral” CLI patients such as those presenting DFS (Figures 2 and 3), or ESRD ischemic
wounds [72, 91–93, 96–98].
6.3. Does topographic WDR allow unrestricted anatomical applications?
The angiosome-oriented revascularization theoretically offers superior chances for healing in
selected ischemic wounds, yet this theory still awaits for further prospective validation in
larger groups of equivalent CLI patients [92, 97].
Lower limb topographic anatomy addressed to date unnumbered ex vivo or clinical works [99–
102] (most of them in the last 50 years) and their analysis largely overpasses the purposes of
this chapter. However, some compelling points should be probably mentioned for better
picturing this impressive graduation in the distribution of the arterial tree toward the target
tissue [35, 101, 102]. The whole body vasculature can be delineated from a “fractal” point of
view, as harmonious repetitive patterns of peripheral tissue irrigation [35, 101]. Particularly
concerning the inferior limb vascularization, this archetype evinces some specific levels of
irrigation [35]. A primary level I of perfusion contains the main arterial and venous bundles (i.e.
iliac and common femoral), the level II gathers first rank arterial branches in the thigh and calf
(i.e. the superficial and profonda femoris and the three tibial trunks), and the next level III
features distinct ramifications for specific skin and underlying tissue zones in the foot [35]. This
level also encompasses the large collaterals (around 1 mm diameter), including the angiosomes
branches, the appended foot arches, and the metatarsal perforators [24, 35, 101], yielding specific
interest in topographic revascularization [23–26, 35, 93, 100]. The next level IV holds the medium-
and small-size (<0.5 mm) collaterals, while next microcirculatory ranks assemble level V that
gathers the arterioles and the level VI connecting the capillary tier (around 8-µm diameter) [39,
101, 103]. This latest convenes several millions of small micrometric conduits in the whole
human body, approximating 60,000 miles of estimated length [102].
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Another parallel and more common anatomical partition used in CLI literature roughly
distinguishes the macrocirculatory rank (that embodies previous levels I–IV) from the microcir-
culatory level (equivalent to other levels V and VI) of limb perfusion [1, 27, 29, 30, 103–106]. By
bridging these two levels, the medium and small muscular arteries and adjacent arterioles
contribute to a continuous pacing system of local tissular perfusion [103–105]. Since CLI threat
appears, this function seems to be notably distorted until focused revascularization is applied
[25, 60, 106].
According to the above considerations, several anatomical variants were equally described,
mainly concerning level III of limb flow distribution [104, 105]. Following two recent meta-
analysis gathering 7671 [107] or 5790 inferior limbs [108], and two “in vivo” analogous
angiographic observations [109, 110], native atypical leg arteries were described in utmost 7.9–
10% individuals out of general population [107–110]. Among these variants, hypoplastic or
aplastic posterior tibial artery was encountered in 3.3% cases, whereas the anterior tibial trunk
was absent in about 1.5% of instances [108]. The presence of highly emergent anterior tibial
artery or irregular tibial trifurcation was described in 5.6–6% cases [109–110], while anomalous
origins of the dorsalis pedis artery were encountered in 4.3–6% presentations [109, 111].
Aberrant first dorsal metatarsal artery and appended first toe dominant irrigation was
described in 8.1% cases [112], parallel variants of the arcuate artery in 5% [113], and modified
courses of the plantar arch and plantar arteries in 5% of presentations [114]. The intimate
knowledge of these variants seems significant for the advised interventionist since wound-
directed revascularization is planned [30, 100]. The presence of one anatomical popliteal variation
(i.e. high origin of the anterior tibial trunk) on one side may indicate possible ipsilateral foot
vessel abnormalities in about 21% of cases [107, 109], and similar contralateral leg variants in
48% of instances [109, 110]. Concomitant acquired arterial flow disturbances were also cited in
lower leg ischemic presentations, most of them accompanying the diabetic neuro-ischemic foot
syndrome [34, 53, 59]. The majority of these anomalies were represented by occlusions of at
least two or all tibial arteries in more than 70% of CLI diabetic subjects [110, 115]. A higher
prevalence of long (>15 cm) obstructions in the posterior tibial and plantar arteries [25, 116,
117] and extensive (type II) calcifications [25, 91] in most diabetic calf and foot arterial segments
were also demonstrated [91]. Our group experience over 232 diabetic CLI limbs [91] with
Wagner grade 2–4 foot wounds [64] availing angiosome-targeted revascularization [24, 96–98],
also confirmed more frequent posterior tibial atherosclerotic occlusive disease (68% of cases
versus 25% anterior tibial and 7% peroneal presentations) [91]. Moreover, the posterior tibial
hypoperfusion showed significant (>90%) concordance with distinct plantar, heel and forefoot
(on the plantar side) skin, and adjacent tissue trophic lesions [25–91].
Although precise below-the-knee arterial anatomical knowledge is of paramount importance in
planning “angiosome-directed” revascularization [91–93], the skilled interventionist should
also corroborate additional hemodynamic information enabled by each collateral pattern [24, 93,
96–98, 118].
Even in the presence of unusual anatomical variants to supply the foot, topographic revascu-
larization still appears feasible [39] by taking advantage either on visible or on unmasked
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arterial branches (the “dormant” collaterals) that gradually reveal during CTO recanalization
[24, 35, 56].
It becomes clearer that since all tibial trunks become occluded, the tipping point between
hypoxic tissue regeneration versus chronic ulceration and necrosis hinges upon the remnant
individual collateral reserve and ways to deliberately use it in addressing the ischemic threat [24,
30, 34, 59].
Despite encouraging results to date [91–93, 96], the angiosome concept may provide better, yet
not complete, ischemic tissue control [35, 61, 72, 118].
Topographic WDR for ulcer healing remains an enthralling subject of discussion. Certainly,
alike similar new openings of flourishing interest in tissue regeneration, the scarcer the
available evidence, the acrider the current debate, mostly based on heterogeneous retrospec-
tive deliberations [35, 72, 92, 96–98, 118].
7. The state of foot collaterals: a key principle in modern CLI wound
treatment
The TASC II recommendation [3] for prompt revascularization in CLI is generally accepted [1,
27], however, do all these interventions address similar extent of ischemic threat? Do all these
interventions bear then, equivalent expectations for tissue recovery? [49] More concretely, does
the modern vascular interventionist truly control all hemodynamic macro- and microvascular
changes at the wound level while performing CLI revascularization? [49, 61, 97] Up-to-date
research reveals that not all proven lower limb ischemic ulcers share the same TASC II/CLI
criteria [3] and, consequently, harbor the corresponding amount of ischemic burden! [2, 31, 49,
61, 118, 119] Owning steady improvement in diagnostic and treatment, modern practitioners
start to adapt current CLI standards to each type of arterial pathology [1, 35, 73, 107], and to
resize ischemic ulcer appraisal in deeper macro- and microcirculatory perception [39, 59–61, 97,
106]. The contemporary medical community is now facing a novel challenge wherein specific
strategies for revascularization in CLI patients with and without a convenient foot collateral
network [92, 96–100, 119]. Thorough research in diabetic CLI treatment had already evinced
good tissue cicatrization since topographic revascularization is performed in subjects having
a poor collateral reserve [26, 92, 96–100, 119]. It is known that DFS currently alter common foot
cutaneous, the underlying tissue and bony presentation, by iterative inflammation, scars,
ischemic necrosis, sensorimotor neuropathy, and local pressure aggressions [57–60]. Even
though that CLI/DFS severely distorts the “classically pictured” angiosomal foot vasculature
[23–25, 96–98], wound-targeted revascularization using the surviving collateral system represents a
valuable solution for better tissue regeneration [92, 96–100, 119].
Today’s evidence suggests that both macro- and microcirculation evaluation should be routinely
considered in each ischemic ulcer presentation toward deeper CLI understanding, as a whole
limb circulatory pattern [39, 105].
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7.1. Compensatory collateral systems relying the foot angiosomes and derived wound
healing implications
An impressive compensatory collateral network interconnecting neighboring foot and ankle
angiosomes was thoroughly documented by previous publications [23, 24, 101, 102], available
as to counterbalance any possible ischemic threat [23, 24, 98].
The central arterial-arterial communicants relying upon different leg angiosomes encompass
numerous small to large collaterals (the above-described levels III and IV), beyond the arterioles
(level V) in a sequential model of perfusion [35, 101]. Numerous “large” foot collaterals hold
particular importance in supplying adjacent angiosomes [24, 39, 118]. They also seem to play
a pivotal role in intentional “wound-directed” revascularization and appropriate tissue
regeneration [35, 96–98, 118]. These vessels assemble the foot arches, (acknowledging eventual
5–9% anatomical variations, Section 6.3) [108–114], the metatarsal perforators, the anterior
communicants, and other sizable arterial-arterial branches such as the dorsal foot-to-plantar, or
the peroneal-to-posterior tibial rescue heel collaterals (level III of perfusion) [35, 101].
In the same design, yet with narrow compensatory significance (Section 6.3), the medium- and
small-sized muscular collateral arteries (level IV) [35] and the arterioles (level V), also contribute
in vital tissue flow preservation [103, 105, 106]. These “rescue” connections were also impli-
cated in the “initiatory” phase of revascularization (Section 4.1) [35, 105] and actively partake
throughout the vast “choke vessels” salvage system [23, 24], before or during the angio- and
arteriogenesis processes [104–106]. Regardless individual variations, the following groups of
arterial-arterial collateral connections were appointed in CLI flow compensation [24, 35, 39,
102, 118]:
• The communications between the posterior tibial and peroneal arteries (via the medial and
lateral calcaneal branches, also via the posterior peroneal branch) play an important role in
ischemic heel ulcers supply, equally for targeted hind foot or heel intentional revasculariza-
tion [24, 72, 96–98].
• The connections between the anterior (dorsalis pedis) and the posterior tibial (plantar) arteries.
These branches ensure either directly via diagonal arteries or following the first metatarsal
perforators or through the metatarsal paired anterior and posterior inter-digital collaterals, a
significant compensation in forefoot and toes ischemic tissue flow preservation and eventual
tarsal/metatarsal reperfusion [24, 35].
• The arterial compensation around the peri-malleolar wounds is reinforced by the lateral peri-
malleolar anastomoses linking the peroneal artery (via the anterior perforating branch) with the
anterior tibial trunk (via the antero-lateral malleolar branch). Following similar, but more
medial connections, the medial peri-malleolar network (sharing similar medial malleolar branches
from the anterior and posterior tibial arteries) represent complementarily, yet distinct,
pathways for blood compensation in the ankle [24, 35].
• The communicants between both plantar arteries (medial and lateral, from the posterior tibial
artery) and the lateral and medial tarsal arteries (via the anterior tibial artery) seem to enable
influential compensatory flow to eventual plantar ischemic wounds [24, 35, 39].
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All these briefly schematized arterial-arterial communications constitute but a small part of the
whole natural foot compensatory system against ischemic aggression [23, 24, 35]. Although
severely compromised in distinct CLI categories of patients (diabetes, ESRD, and inflammatory
arteritis) [59–61, 104], all these “rescue branches” [35, 59, 101, 102] or “choke-vessels” [23, 24]
provide noticeable flow assistance during miscellaneous ischemic injuries. Their appropriate
evaluation affords valuable diagnostic and therapeutic knowledge for better tissue preserva-
tion and limb salvage [39, 56–59].
In this exhaustive “regional view” of ischemic tissue perfusion, albeit more precise than blunt
angiographic assessment (Section 4.5), it appears that not all foot areas may express similar ischemic
affliction [59–61, 104]. Even more surprisingly, the ulcer’s area could not always stand for the
lowest perfusion point in the ischemic limb, since severe neuropathy, inflammatory swelling,
sepsis, and local skin trauma may add complementary hindrance to main CLI threat [26, 27,
31, 33].
Future diagnostic tools focusing on superficial and deep tissue “wound-oriented” arterial flow
may eventually complete this unique holistic view of the neuro-ischemic diabetic foot [33, 39,
53, 59].
We know today that diabetic and renal CLI patients express serious tissue regeneration
handicap, inflicted by specific infragenicular arterial collateral depletion [29–31]. This
significant decay in tissue regeneration also appears proportionate with the type and time of
ischemic suffering [1, 2, 27, 30, 59]. In this perspective, recent researchers advise reasonable
adaptation of current revascularization indications upon individual macro [3, 41] and micro-
vascular CLI characteristics [29–31, 39], weighted in patients with and without available
collateral reserve [29, 39, 59].
8. The essential role of multidisciplinary approach in ischemic ulcer
healing
Increasing clinical evidence suggests that despite “well-suited” revascularization efforts, at
least 25% of DFS ulcers will eventually not heal, and around 28% may end however with some
form of amputation [58, 120].
It appears unmistakable that no current single therapy can enhance alone profitable healing
results in a majority of CLI ulcers [1, 27, 58] without concomitant management of all risk factors,
including ischemic, metabolic, septic, local pressure, neuropathic, and adequate off-loading
appointed treatment [1–3, 120–123]. Wound healing embodies a complex cascade of molecular
and clinical events in continuous dynamic interaction [34, 48]. It was stated that because CLI
wound etiology is always multidimensional [1, 27, 58], specific therapy in turns requires a
parallel multidisciplinary application [1–3, 120, 121].
Every individual risk factor requires accurate identification and management and represents
a fundamental task for any multidisciplinary wound center to encourage [124]. Investing
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healing as the primary endpoint in care acts as a real benchmark for all collective therapeutic
efforts [57, 87, 124].
The recent guidelines document of the Society for Vascular Surgery connecting with the
American Podiatric Medical Association and the Society for Vascular Medicine acts as a great
reference to current evidence of ischemic wound treatment [120]. This noteworthy analysis
addresses best available proofs and guidelines to date on the following main indicators: (1)
prevention of diabetic foot ulceration, (2) off-loading, (3) diagnosis of sepsis and foot osteo-
myelitis, (4) specific wound care, and (5) peripheral arterial disease in DFS [120].
Prevention following evidence-based program includes the patient and the referral General
Practitioners (GP) as active members of the multidisciplinary group [120–123]. Knowing that
peripheral neuropathy can generate about 45–65% of DFS ulcers, patients with neuropathy
hold >3.5-fold complementary risk for iterative neuro-ischemic ulceration [26, 71, 87, 120].
Adequate laboratory tests surveillance also represents a critical method as to minimize detri-
mental obstacles in tissue regeneration [120–123]. It has been recorded that for every additional
1% increase in HbA1C, there is a 0.028 cm/day healing decay in DFS wounds [120–125]. The
major importance of off-loading devices in the global healing process is acknowledged [57, 58,
120–122]. Pressure reduction is reputed to allow superior healing effects to any revasculariza-
tion strategy [2, 57, 58, 120–124]. Early diagnostic and treatment of foot infection also have
paramount consequences in correct tissue regeneration [2, 57–59, 120–122]. Expeditious local
wound debridement following timely reevaluation schedule bears huge implications for
maintaining tissue viability, parallel to revascularization [57–59]. Since aggressively applied,
early debridement can save millimeters of “time-dependent” irreversible damage [2, 57, 58,
61, 87, 120–124].
Appropriate wound dressing should help by maintaining a moist wound bed, providing exudate
drainage, and urging granulation of tissue defect [53, 57, 120, 126].
The adapted dressing should match each specific CLI pathology, wound features and location,
and individual amount of exudates, inflammation, and pain [87, 88, 120, 126].
New complementary therapies including negative pressure therapy, living cellular therapy,
extracellular matrix products, and hyperbaric oxygen therapy were equally developed in the
last years [57, 127]. Their application should follow multidisciplinary team advises [88, 120,
127] in ulcers that fail to demonstrate >50% area reduction per month, using standard therapy
[120, 127].
Although revascularization still holds specific postoperative indicators [33, 39], the global
efficacy of multidisciplinary approach can be timely rated by percentage reduction in wound
extent as an early predictor of clinical success [120, 126]. Wound surface diminution of 10–15%
per week, or >50% in 4 weeks strongly suggests increased likelihood of healing and diminished
probability for amputation [120, 121, 126].
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8.1. Ischemic wound healing as an integrated medicine concept
The contemporary practitioner becomes aware that every ischemic ulcer presentation should
be carefully weighted and treated alike distinct pathological prototype. It appears reasonable that
for every single ulcer puzzling (in various amounts) possible neuropathic, ischemic, hyper-
glycemic, uremic, venous hypoxic, septic, hypoproteic, or pressure threats, only a multimodal
team approach may afford better healing expectations [121–126, 128, 129]. Every chronic
ulceration case can be theoretically approached alike a 3-D graphical mold assembling in
different proportions of some or the whole of the determinants mentioned above. The vital
role of any multidisciplinary team is to decode each clinical presentation into basic pathological
influences and treat them upon best available knowledge granted by all participant specialties
[121, 123, 126].
9. Conclusions
In treating arterial ulcers it should be remembered that not all foot sectors share same ischemic
affectation and that not all patients with comparable macro-vascular images bear same
collateral reserve and related micro-vascular tissue recovery resources.
Contemporary research reveals astonishing multilevel anatomical and physiological intricacy
of lower limb blood supply, viewed in a dynamic and time unfolding perspective. This
apparent complexity represents but plausible challenges for the experienced interventionist
availing high-performance macro and microcirculatory diagnostic and treatment methods for
revascularization and tissue healing.
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